MME and breast carcinoma: In breast cancer, many studies reported that the stromal CD10 expression is associated with more biologically aggressive tumors [12–14] and they have addressed the clinical significance of CD10 expression, however the use of CD10 for diagnosis and prognosis remain unclear [15].